Animal biotechnology is a branch of biotechnology in which molecular biology techniques are used to genetically engineer (i.e. modify the genome of) animals in order to improve their suitability ...

In a game-changing move, NEEF’s Director of Operations, Kisa Kaloloweska, announced that the fund is ready to step in and renovate both housing units and office complexes for extension workers.

In a sign it is willing to go further in responding to President Trump’s tariffs, Beijing blocked more American companies from importing goods into China. By Alexandra Stevenson Reporting from ...

First, let’s take a look at the private biotech investments in February 2025, breaking them down by value, location, funding type, and therapeutic subsector. In February 2025, Eikon Therapeutics ...

Novo Nordisk has forged a deal with Gensaic, agreeing to pay up to $354 million per target to access technology for the tissue-selective delivery of molecules to cardiometabolic targets inside cells.

The miss fell in the hands of Te-Hina Paopao, the crowd elevated and with eight seconds left, sophomore guard Tessa Johnson launched a 3-pointer. Bang. "I was just going with the momentum of the ...

No sector is left unchanged by the power of AI and digital modeling, and Biotech is no exception. This is because biology is by far the most “messy” of hard sciences. Chemistry or physics can deal ...

No matter the market environment, you’ll always find entertainment in the biotech space. There will always be biotech stocks making huge swings in both directions and these stocks can make or ...

True, this mid-cap biotech still looks risky. It has yet to start late-stage studies for any candidate. And like most clinical-stage biotechs, Viking generates no revenue and is unprofitable.

A San Francisco biotech company said Wednesday that it has developed an antiaging pill for dogs that might be able to help extend the life of your furry friend. It can be prescribed for canines ...

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. Health care investor Kevin Tang buys ...